| (Values in U.S. Thousands) | Oct, 2016 | Oct, 2015 | Oct, 2014 | Jan, 2018 | Oct, 2017 |
| Sales | 1,866,700 | 1,774,200 | 1,483,500 | 0 | 0 |
| Sales Growth | +5.21% | +19.60% | unch | unch | unch |
| Net Income | 31,700 | 138,400 | -119,200 | 0 | 0 |
| Net Income Growth | -77.10% | +216.11% | unch | unch | unch |
Patheon Nv (PTHN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Patheon N.V. is a provider of pharmaceutical development and manufacturing services. Patheon N.V. is based in Amsterdam, Netherlands.
Fiscal Year End Date: 10/31